2,3-二氢-1H-吲哚-4-甲腈盐酸盐 | 885278-80-8

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吲哚及其衍生物
• 中文名称: 2,3-二氢-1H-吲哚-4-甲腈盐酸盐
• 中文别名: 2,3-二氢-1H-吲哚-4-甲腈
• 英文名称: indoline-4-carbonitrile
• 英文别名: 2,3-dihydro-1H-indole-4-carbonitrile
• CAS: 885278-80-8
• 化学式: C₉H₈N₂
• 分子量: 144.176
• InChiKey: QRRLRJLHVTVIEF-UHFFFAOYSA-N

物化性质

• 沸点：
  304.5±31.0 °C(Predicted)
• 密度：
  1.18±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.7
• 重原子数：
  11
• 可旋转键数：
  0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.22
• 拓扑面积：
  35.8
• 氢给体数：
  1
• 氢受体数：
  2

安全信息

• 海关编码：
  2933990090

反应信息

• 作为反应物：
  描述：

  2,3-二氢-1H-吲哚-4-甲腈盐酸盐 在 potassium carbonate 作用下， 以 N,N-二甲基乙酰胺 、 丁酮 为溶剂， 反应 70.0h， 生成 methyl 4-[(2S)-3-(4-cyano-2,3-dihydroindol-1-yl)-2-hydroxy-2-methyl-3-oxopropoxy]benzoate
  参考文献：
  名称：

  1-(2-Hydroxy-2-methyl-3-phenoxypropanoyl)indoline-4-carbonitrile Derivatives as Potent and Tissue Selective Androgen Receptor Modulators

  摘要：

  We present a novel series of selective androgen receptor modulators (SARMs) which shows excellent biological activity and physical properties. 1-(2-Hydroxy-2-methyl-3-phenoxypropanoyl)-indoline-4-carbonitriles showed potent binding to the androgen receptor (AR) and activated AR-mediated transcription in vitro. Representative compounds demonstrated diminished activity in promoting the intramolecular interaction between the AR carboxyl (C) and amino (N) termini. This N/C-termini interaction is a biomarker assay for the undesired androgenic responses in vivo. In orchidectomized rats, daily administration of a lead compound from this series showed anabolic activity by increasing levator ani muscle weight. Importantly, minimal androgenic effects (increased tissue weights) were observed in the prostate and seminal vesicles, along with minimal repression of circulating luteinizing hormone (LH) levels and no change in the lipid and triglyceride levels. This lead compound completed a two week rat toxicology study, and was well tolerated at doses up to 100 mg/kg/day, the highest dose tested, for 14 consecutive days.

  DOI：

  10.1021/jm401625b
• 作为产物：
  描述：

  4-溴二氢吲哚 在 sodium hydroxide 作用下， 以 四氢呋喃 、 二氯甲烷 、 N,N-二甲基甲酰胺 为溶剂， 反应 20.0h， 生成 2,3-二氢-1H-吲哚-4-甲腈盐酸盐
  参考文献：
  名称：

  1-(2-Hydroxy-2-methyl-3-phenoxypropanoyl)indoline-4-carbonitrile Derivatives as Potent and Tissue Selective Androgen Receptor Modulators

  摘要：

  We present a novel series of selective androgen receptor modulators (SARMs) which shows excellent biological activity and physical properties. 1-(2-Hydroxy-2-methyl-3-phenoxypropanoyl)-indoline-4-carbonitriles showed potent binding to the androgen receptor (AR) and activated AR-mediated transcription in vitro. Representative compounds demonstrated diminished activity in promoting the intramolecular interaction between the AR carboxyl (C) and amino (N) termini. This N/C-termini interaction is a biomarker assay for the undesired androgenic responses in vivo. In orchidectomized rats, daily administration of a lead compound from this series showed anabolic activity by increasing levator ani muscle weight. Importantly, minimal androgenic effects (increased tissue weights) were observed in the prostate and seminal vesicles, along with minimal repression of circulating luteinizing hormone (LH) levels and no change in the lipid and triglyceride levels. This lead compound completed a two week rat toxicology study, and was well tolerated at doses up to 100 mg/kg/day, the highest dose tested, for 14 consecutive days.

  DOI：

  10.1021/jm401625b

文献信息

• Reductive cyanation of organic chlorides using CO2 and NH3 via Triphos–Ni(I) species
  作者：Yanan Dong、Peiju Yang、Shizhen Zhao、Yuehui Li

  DOI：10.1038/s41467-020-17939-2

  日期：——

  pharmaceuticals, agrochemicals and organic materials. Traditional cyanation methods often rely on the use of toxic metal cyanides which have serious disposal, storage and transportation issues. Therefore, there is an increasing need to develop general and efficient catalytic methods for cyanide-free production of nitriles. Here we report the reductive cyanation of organic chlorides using CO2/NH3 as the electrophilic

  含氰化合物是重要的药物、农用化学品和有机材料。传统的氰化方法通常依赖于有毒金属氰化物的使用，这些氰化物具有严重的处置、储存和运输问题。因此，越来越需要开发通用且有效的催化方法来生产无氰腈。在这里，我们报告了使用 CO 2 /NH 3对有机氯化物进行还原氰化作为亲电子 CN 源。使用三齿膦配体 Triphos 可以使多种芳基和脂肪族氯化物在镍催化下氰化，从而以良好的收率和优异的官能团耐受性生产所需的腈产物。廉价且在工作台上稳定的尿素也被证明是合适的 CN 来源，表明具有广阔的应用潜力。机理研究表明，Triphos-Ni(I) 物种负责涉及异氰酸酯中间体的还原性 CC 偶联方法。该方法扩展了还原氰化在无氰条件下合成功能化腈化合物的应用潜力，这对于（同位素标记）药物的安全合成具有重要价值。
• Heterocyclic-substituted phenyl methanones
  申请人：Jolidon Synese

  公开号：US20060178381A1

  公开（公告）日：2006-08-10

  The present invention relates to compounds of formula I wherein R 1 , R 2 , and are defined in the specification and to pharmaceutically acceptable acid addition salts thereof.

  本发明涉及式I的化合物 其中 R 1 ， R 2 ，并在规范中定义，并且其药学上可接受的酸盐。
• Gold-catalyzed C5-alkylation of indolines and sequential oxidative aromatization: access to C5-functionalized indoles
  作者：Wenzheng Zhang、Guangyang Xu、Lin Qiu、Jiangtao Sun

  DOI：10.1039/c8ob00826d

  日期：——

  novel protocol for the synthesis of C5-alkylated indole derivatives via a gold-catalyzed reaction of indolines with diazo compounds and subsequent oxidative aromatization has been developed. C–H bond functionalization selectively occurs at the C5-position of indolines without a directing group. The experimental operation is simple and the whole process can be manipulated in one-pot.

  已经开发了通过二氢吲哚与重氮化合物的金催化反应和随后的氧化芳构化来合成C5-烷基化的吲哚衍生物的新方案。C–H键功能化选择性地发生在二氢吲哚的C5位置，没有任何导向基团。实验操作简单，整个过程可以一锅进行。
• [EN] N-CYCLYL-3 - (CYCLYLCARBONYLAMINOMETHYL) BENZAMIDE DERIVATIVES AS RHO KINASE INHIBITORS<br/>[FR] DÉRIVÉS DE N-CYCLYL-3-(CYCLYLCARBONYLAMINOMÉTHYL)BENZAMIDE EN TANT QU'INHIBITEURS DE LA RHO KINASE
  申请人：BOEHRINGER INGELHEIM INT

  公开号：WO2012006203A1

  公开（公告）日：2012-01-12

  The present invention relates to compounds of formula (I) : and pharmaceutically acceptable salts thereof, wherein R1and R2 are various ring systems. The invention also relates to pharmaceutical compositions comprising these compounds, methods of using these compounds in the treatment of Rho Kinase mediated diseases and disorders, processes for preparing these compounds and intermediates useful in these processes.

  本发明涉及化合物的公式（I）及其药学上可接受的盐，其中R1和R2是不同的环系统。该发明还涉及包括这些化合物的药物组合物，使用这些化合物治疗Rho激酶介导的疾病和障碍的方法，制备这些化合物的方法以及在这些过程中有用的中间体。
• [EN] RHO KINASE INHIBITORS<br/>[FR] INHIBITEURS DE LA RHO KINASE
  申请人：BOEHRINGER INGELHEIM INT

  公开号：WO2012006202A1

  公开（公告）日：2012-01-12

  The present invention relates to compounds of formula (I): and pharmaceutically acceptable salts thereof, wherein R1 and X are as defined herein. The invention also relates to pharmaceutical compositions comprising these compounds, methods of using these compounds in the treatment of Rho Kinase-mediated disorders selected from hypertension, atherosclerosis, restenosis, stroke, myocardial infarction, heart failure, coronary artery disease, peripheral artery disease, coronary vasospasm, cerebral vasospasm, ischemia/reperfusion injury, pulmonary hypertension, angina, erectile dysfunction, renal disease, organ failure, asthma, glaucoma, cancer, Alzheimer's disease, multiple sclerosis, spinal cord injury, neuropathic pain, rheumatoid arthritis, psoriasis inflammatory bowel disease, and combinations of such disorders.

  本发明涉及化合物的结构式（I）及其药学上可接受的盐，其中R1和X如本文所定义。本发明还涉及包含这些化合物的制药组合物，以及使用这些化合物治疗从高血压、动脉粥样硬化、再狭窄、中风、心肌梗死、心力衰竭、冠状动脉疾病、外周动脉疾病、冠状动脉痉挛、脑血管痉挛、缺血/再灌注损伤、肺动脉高压、心绞痛、勃起功能障碍、肾脏疾病、器官衰竭、哮喘、青光眼、癌症、阿尔茨海默病、多发性硬化症、脊髓损伤、神经性疼痛、类风湿性关节炎、银屑病、炎症性肠病等Rho激酶介导的疾病的方法，以及这些疾病的组合。